Synthesis of results
The postoperative serum AMH levels (Figure 3) of the endometrioma
patients in the electrocoagulation group were significantly lower than
those of the nonthermal hemostatic method group at postoperative one
month (mean difference [MD] 0.72, 95% confidence interval (CI)
[0.42, 1.03]), three months ([MD]0.68, 95% CI [0.27,
1.09]), six months ([MD] 0.65, 95% CI [0.27, 1.03]), and 12
months ([MD] 0.86, 95% CI [0.69, 1.04]). These findings suggest
a more pronounced negative impact of electrocoaguation on the ovarian
reserve of endometrioma patients 3, 16, 17, 20, 24,
25. However, when analyzing patients with benign ovarian cysts, no
significant difference was found between the two groups at postoperative
three months ([MD] -0.13, 95%CI [-1.61, 1.35]), six months
([MD] 0.3, 95% CI [0.02, 0.59]), and 12 months ([MD] 0.39,
95% CI [-1.13, 1.91]). The funnel plot indicated the absence of
significant publication bias for the outcome of postoperative 3-month
serum AMH.
When comparing the two groups with regard to AFC 4, 17,
19, 22, 24(Figure 4.), a statistically significant decrease was
observed in the endometrioma subgroup at postoperative months 1, 3, and
12. Nevertheless, the AFC difference was insignificant in the studies
including various types of benign ovarian cysts 4, 19.